CLAYTON,Novo Nordisk will invest $100 million and add 187 new jobs at its facility in Clayton, Gov. Mike Easley announced Thursday.

The pharmaceutical giant received incentives from the state for the expansion, including the Job Development Investment Grant and the One North Carolina Fund.

Novo Nordisk has 19,600 employees spread across 69 countries. It already employs more than 350 in Clayton.

Its Clayton facility will double its insulin manufacturing capability by 2006. Twp assembly and packaging lines will be added in 2007, according to the announcement.

Novo Nordisk has developed a pen-line device for insulin delivery.

The One North Carolina Fund will grant the company up to $250,000 and develop a customized training program for workers that will be utilized through the state’s community college system. The Job Development Investment grant for creation of new jobs will be spread over 10 years.

“One of the main reasons Novo Nordisk is expanding here is because of the training their employees will receive through the community college system,” Easley said.

Novo Nordisk: www.novonordisk.com